Advertisement
Screener

Evome Medical Technologies, Inc. Share-based Payment Arrangement, Expense

Evome Medical Technologies, Inc. Share-based Payment Arrangement, Expense

Evome Medical Technologies, Inc. reported Share-based Payment Arrangement, Expense of CAD 1.29 million for the 12-month period ending 2023-12-31, per its 10-K filed 2024-04-16.

Discontinued › Expense Statement › Operating Expenses

us-gaap:AllocatedShareBasedCompensationExpense · last filed 2024-04-16

  • Evome Medical Technologies, Inc. share-based payment arrangement, expense for the quarter ending 2023-12-31 was 286.72K CAD, a 24.73% decline year-over-year.
  • Evome Medical Technologies, Inc. share-based payment arrangement, expense for the quarter ending 2023-09-30 was 264.64K CAD, a 30.12% decline year-over-year.
  • Evome Medical Technologies, Inc. share-based payment arrangement, expense for the quarter ending 2023-06-30 was 46.05K CAD, a 8.85% decline year-over-year.
  • Evome Medical Technologies, Inc. share-based payment arrangement, expense for the quarter ending 2023-03-31 was 345.52K CAD, a 21.22% decline year-over-year.
  • Evome Medical Technologies, Inc. share-based payment arrangement, expense for fiscal 2023 was 1.29M CAD.
  • Evome Medical Technologies, Inc. share-based payment arrangement, expense for fiscal 2022 was 1.20M CAD, a 403.28% increase from fiscal 2021.
  • Evome Medical Technologies, Inc. share-based payment arrangement, expense for fiscal 2021 was 237.71K CAD.
Period endShare-based Payment Arrangement, Expense 3 monthShare-based Payment Arrangement, Expense 6 monthShare-based Payment Arrangement, Expense 9 monthShare-based Payment Arrangement, Expense 10 monthShare-based Payment Arrangement, Expense 12 month
2023-12-31286.72K CAD
derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-16
551.36K CAD
derived: sum of 2 quarters · filed 2024-04-16
597.41K CAD
derived: sum of 3 quarters · filed 2024-04-16
1.29M CAD
10-K · filed 2024-04-16
2023-09-30264.64K CAD
10-Q · filed 2023-11-14
310.69K CAD
derived: sum of 2 quarters · filed 2023-11-14
1.00M CAD
10-Q · filed 2023-11-14
2023-06-3046.05K CAD
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14
391.57K CAD
10-Q · filed 2023-08-14
2023-03-31345.52K CAD
10-Q · filed 2023-05-15
2022-12-311.28M CAD
10-K · filed 2024-04-16
2022-11-30380.94K CAD
10-Q · filed 2023-01-17
1.25M CAD
10-Q · filed 2023-01-17
2022-09-30378.68K CAD
10-Q · filed 2023-11-14
1.31M CAD
10-Q · filed 2023-11-14
2022-08-31378.68K CAD
10-Q · filed 2022-10-17
867.77K CAD
10-Q · filed 2022-10-17
2022-06-3050.52K CAD
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14
489.09K CAD
10-Q · filed 2023-08-14
2022-05-31489.09K CAD
10-Q · filed 2022-07-15
2022-03-31438.57K CAD
10-Q · filed 2023-05-15
2022-02-28438.57K CAD
derived: 10-K 12 month − 10-Q 9 month · filed 2022-05-31
731.06K CAD
derived: sum of 2 quarters · filed 2023-01-17
1.18M CAD
derived: sum of 3 quarters · filed 2023-01-17
1.20M CAD
10-K · filed 2022-05-31
2021-11-30292.49K CAD
10-Q · filed 2023-01-17
738.71K CAD
derived: sum of 2 quarters · filed 2023-01-17
757.79K CAD
10-Q · filed 2023-01-17
859.50K CAD
derived: sum of 4 quarters · filed 2023-01-17
2021-08-31446.21K CAD
10-Q · filed 2022-10-17
465.30K CAD
10-Q · filed 2022-10-17
567.01K CAD
derived: sum of 3 quarters · filed 2022-10-17
636.21K CAD
derived: sum of 4 quarters · filed 2022-10-17
2021-05-3119.09K CAD
10-Q · filed 2022-07-15
120.80K CAD
derived: sum of 2 quarters · filed 2022-07-15
190.00K CAD
derived: sum of 3 quarters · filed 2022-07-15
245.59K CAD
derived: sum of 4 quarters · filed 2022-07-15
2021-02-28101.71K CAD
derived: 10-K 12 month − 10-Q 9 month · filed 2022-05-31
170.91K CAD
derived: sum of 2 quarters · filed 2022-05-31
226.51K CAD
derived: sum of 3 quarters · filed 2022-05-31
237.71K CAD
10-K · filed 2022-05-31
2020-11-3069.20K CAD
10-Q · filed 2022-01-14
124.80K CAD
derived: sum of 2 quarters · filed 2022-01-14
136.00K CAD
10-Q · filed 2022-01-14
2020-08-3155.60K CAD
10-Q · filed 2021-10-15
66.80K CAD
10-Q · filed 2021-10-15
2020-05-3111.21K CAD
10-Q/A · filed 2021-08-02